Detecting Clinically Significant Prostate Cancer With Advanced MRI Protocols and Extensive Histopathology

Clinical trial NCT07432360 · RECRUITING

Trial details

NCT number: NCT07432360
Sponsor: Virdx, Inc.
Status: RECRUITING
Study type: OBSERVATIONAL

Prostate Cancer

Start date: 2026-01-28
Primary completion: 2028-06-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.